|
Dear Colleague,
GTC is proud to present our largest summit of the year, the Omics Evolution
2012, to be held on May 29th-31st in Boston,
Massachusetts. The Summit will bring together leading pharmaceutical and
diagnostic companies, top scientists and government experts to discuss research
and developments in drug discovery, new technologies and the evolving landscape
of the industry in genomics, proteomics, RNAi, next-generation sequencing,
epigenetics and protein kinases.
The Summit will have six tracks
and a workshop that will allow attendees to engage in individual programs – or
portions of all tracks – while enjoying networking opportunities with all
attendees, speakers, poster presenters and exhibitors:
Clinical Sequencing Workshop
2nd Genomic & Proteomic Drug Discovery
2nd Next Generation Sequencing
2nd Epigenetics in Drug Discovery
3rd RNAi Research and Development
7th Protein Kinases in Drug Discovery
Genome-wide Partnering & Dealmaking
|
The Summit features the following Conferences sessions:
Clinical Sequencing Workshop:
Emerging Next-Generation Sequencing Technologies and its Clinical
Applications
The Implementation of Next-Generation Sequencing in a CLIA Laboratory -
Issues and Challenges
Translation of NextGen sequencing from research applications to a
standardized lab developed test in a CLIA environment
Measuring and Ensuring Quality in NGS
2nd Genomic & Proteomic Drug Discovery:
Pharmaco-omics
Advances in Genomic Medicine
Identification and Validation of Drug Targets
Systems Biology for Therapeutic and
Diagnostic Discovery
2nd Next Generation Sequencing:
Novel Sequencing Strategies
Next Next Generation Sequencing
Applications of NGS Platforms
Analysis and Data Management
Sequencing Technology and Software
2nd Epigenetics in Drug Discovery:
Epigenetic Mechanisms
Role of Epigenetics in Human Diseases
Enabling Technologies for Epigenetics Drug Discovery
Drug Discovery in Epigenetics
Preclinical and Clinical Development in Epigenetics
Diagnostics and Therapeutic Trends in Epigenetics
3rd RNAi Research and Development:
RNAi Delivery Methods
Gene Activation and Silencing by Small RNAs
Target Validation
Therapeutic, Diagnostics and Clinical Applications
MicroRNA and Diseases
*Sub-Session: ncRNAs, lncRNA
7th Protein Kinases in Drug Discovery:
Overcoming Challenges in Kinase Drug Development
Trends in Drug Design – Structure/Selectivity/Pathway/Epigenetics
Oncology Kinases & Inhibitor Candidates
Other Kinases & Inhibitor Candidates
Pre-Clinical Kinase Targets to Clinical Trials
Genome-wide Partnering & Deal-making:
Partnering for Personalized Medicine
Technologies in Genomic and Diagnostics
Partnering
Companion Diagnostic Partnering Business Models
Reimbursement Issues and Trends
Genome-wide ELSI (Ethical, Legal and Social Issues)
Panel Discussion: The Future of Pharma-Diagnostic Partnering
Panel Discussion: Genome-wide Industry and Academia Collaboration |
| |
Kind Regards,
2012 Conference Advisory Committee
|
|
